🔎 Trials Near Me

Dachaigh › Depression › Connecticut

Sgrùdaidhean clionaigeach Depression ann an Connecticut

Tha 15 sgrùdaidhean airson Depression a’ lorg phàirtichean aig làraichean ann an Connecticut.

Bailtean ann an Connecticut

Teacsa sgrùdaidh oifigeil (Beurla)

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  • Yale School of Medicine - Yale Program for Psychedelic Science, New Haven
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06793397

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Yale University School of Medicine, New Haven
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07412756

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

  • Yale University, New Haven
A’ fastadhÌre 2
Aoisean 40 gu 80 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07610369

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

  • Seaport Investigator Site, Cromwell
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07065240

PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study

  • Mood Institute, Milford
  • Yale School of Medicine, New Haven
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06713616

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

  • Institute of Living, Hartford
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407

E-Mindfulness Approaches for Living After Breast Cancer

  • Stamford Hospital/Bennett Cancer Center, Stamford
A’ fastadhÌre 3
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06748222

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  • Ct Clinical Research Associates, Cromwell
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06775379

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Cromwell
  • Neurocrine Clinical Site, Farmington
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401

Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans

  • Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,, West Haven
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 21 gu 65 · Gach gnè · Air ùrachadh 16 Ògmh 2026 · NCT06671977

Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life

  • Yale University, New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05810259

The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects

  • VA Connecticut Healthcare System, West Haven
A’ fastadhÌre 2
Aoisean 21 gu 65 · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT05786066

Stress and Pain in People Living With HIV

  • The Yale Stress Center, New Haven
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 68 · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT06784908

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

  • https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceL, Darien
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 44 · Banairean · Air ùrachadh 15 Gibl 2026 · NCT06788977

Open-Label Psilocybin Study in Transdiagnostic Population

  • Connecticut Mental Health Center - Yale School of Medicine, New Haven
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Màrt 2026 · NCT06442423

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.